Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Creyon Bio engineers oligonucleotide-based medicines to create tissue-aware, precision RNA therapies that are safer and more predictable for patients. The company uses a data-first, AI-driven…

Creyon Bio engineers oligonucleotide-based medicines to create tissue-aware, precision RNA therapies that are safer and more predictable for patients. The company uses a data-first, AI-driven…
Founded: 2019
Focus: AI-driven design of oligonucleotide (RNA) therapeutics and tissue-targeted delivery
Lead programs: Neuromuscular and CNS programs advancing toward clinical development
Series A: $40.0M (Mar 2022)
Headquarters / offices: Carlsbad, CA and Durham, NC
Design and delivery of oligonucleotide (RNA) therapeutics for neuromuscular, CNS, and immunology indications.
2019
Biotechnology
$40.0M
Series A included multiple investors (reported five investors total).
“DCVC Bio and Lux Capital identified as lead investors in Series A”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week